Therapeutic class
Anticoagulant, inhibiteur direct de la thrombine, monovalent
4 drugs listed in Morocco
This page lists drugs marketed in Morocco belonging to the therapeutic class "Anticoagulant, inhibiteur direct de la thrombine, monovalent". For each entry, you'll find the brand name, composition (DCI), dosage, galenic form, manufacturer, public selling price (PPV in MAD) and reimbursement status (CNSS / CNOPS). Primary source: Direction du Médicament et de la Pharmacie (DMM), Ministry of Health.
PRADAXA 110 MG
110 MG · Gélule
Dabigatran étexilate
Anticoagulant, inhibiteur direct de la thrombine, monovalent
BOTTU S.A.
365 MAD
PRADAXA 110 MG
110 MG · Gélule
Dabigatran étexilate
Anticoagulant, inhibiteur direct de la thrombine, monovalent
BOTTU S.A.
733 MAD
PRADAXA 150 MG
150 MG · Gélule
Dabigatran étexilate
Anticoagulant, inhibiteur direct de la thrombine, monovalent
BOTTU S.A.
803 MAD
PRADAXA 75 MG
75 MG · Gélule
Dabigatran étexilate
Anticoagulant, inhibiteur direct de la thrombine, monovalent
BOTTU S.A.
530 MAD